Past its pain-relieving outcomes, conolidine has shown a positive security margin in preclinical toxicology assessments. Not like opioids, which often lead to respiratory depression at increased doses, conolidine hasn't developed indications of sizeable respiratory suppression. Additionally, behavioral assessments in murine types suggest an absence of drug-in search of behaviors, https://raymondo470zwr1.bloggazza.com/profile